Investor J. Goldman & Co LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by J. Goldman & Co LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2026-05-15 13G/A DSAC / Daedalus Special Acquisition Corp. 1,250,000
2026-02-17 13G ANDG / Andersen Group Inc. 1,160,000
2026-02-17 13G TVA / Texas Ventures Acquisition III Corp 1,216,321
2026-02-17 13G/A ONCH / 1RT Acquisition Corp. 1,078,125 862,500
2026-02-17 13G/A PCAP / ProCap Acquisition Corp 1,595,550 1,445,321
2026-02-17 13G/A DMYY / dMY Squared Technology Group, Inc. 150,000 0
2026-02-17 13G DSACU / Daedalus Special Acquisition Corp. - Debt/Equity Composite Units 1,487,500
2025-11-14 13G/A ZIMV / ZimVie Inc. 1,425,810 0
2025-11-14 13G/A MCGAU / Yorkville Acquisition Corp. - Debt/Equity Composite Units 800,000 0
2025-11-14 13G/A GRDN / Guardian Pharmacy Services, Inc. 751,084 656,860
2025-11-14 13G/A DMYY / dMY Squared Technology Group, Inc. 225,000 150,000
2025-11-14 13G PCAP / ProCap Acquisition Corp 1,595,550
2025-11-14 13G ONCH / 1RT Acquisition Corp. 1,078,125
2025-08-14 13G MCGAU / Yorkville Acquisition Corp. - Debt/Equity Composite Units 800,000
2025-08-14 13G EGRX / Eagle Pharmaceuticals, Inc. 667,108
2025-08-14 13G/A DMYY / dMY Squared Technology Group, Inc. 192,811 225,000
2025-05-15 13G DMYY / dMY Squared Technology Group, Inc. 192,811
2025-02-14 13G ZIMV / ZimVie Inc. 1,425,810
2024-11-14 13G GRDN / Guardian Pharmacy Services, Inc. 751,084
2024-11-14 13G/A NLOP / Net Lease Office Properties 1,035,861 672,455
2024-02-14 13G NLOP / Net Lease Office Properties 1,035,861
2023-02-14 13G RONI / Rice Acquisition Corp II - Class A 1,760,506
2022-02-14 13G/A YVR / Liquid Media Group Ltd 0 0
2021-02-16 13G/A FREE / Whole Earth Brands, Inc. 0
2021-02-16 13G/A G4603R114 / HL Acquisitions Corp. 0
2021-02-16 13G YVR / Liquid Media Group Ltd 0
2021-02-16 13G/A US3828722088 / Gores Metropoulos, Inc. 0
2021-02-16 13G / Aspirational Consumer Lifestyle Corp. 1,773,752
2021-02-16 13G/A CTRN / Citi Trends, Inc. 550,460 501,064
2021-02-16 13G/A G3165V117 / ARYA SCIENCES ACQUISITION CORP. 178,067
2020-07-13 13G CTRN / Citi Trends, Inc. 550,460 550,460
2020-07-10 13G CTRN / Citi Trends, Inc. 550,460
2020-02-14 13G/A AEZS / COSCIENS Biopharma Inc.
2020-02-14 13G G4603R114 / HL Acquisitions Corp.
2020-02-14 13G US3828722088 / Gores Metropoulos, Inc.
2020-02-14 13G G3165V117 / ARYA SCIENCES ACQUISITION CORP.
2020-02-14 13G FREE / Whole Earth Brands, Inc.
2020-02-14 13G/A STNL / Sentinel Energy Services Inc.
2019-02-11 13G AEZS / COSCIENS Biopharma Inc.
2019-02-11 13G STNL / Sentinel Energy Services Inc.
2018-02-13 13G/A MIIIW / M III Acquisition Corp.
2018-02-13 13G/A COVS / Covisint Corporation
2017-06-26 13D/A SCOO / School Specialty, LLC
2017-06-26 13G MIIIW / M III Acquisition Corp.
2017-06-26 13G COVS / Covisint Corporation
2017-05-15 13D/A SCOO / School Specialty, LLC
2017-03-31 13D/A SCOO / School Specialty, LLC
2017-02-14 13G COVS / Covisint Corporation
2017-02-14 13G MIIIW / M III Acquisition Corp.
2016-02-16 13G COVS / Covisint Corporation
2015-02-13 13G ALQA / Alliqua, Inc.
2014-02-14 13G FEED / ENvue Medical, Inc. 6,625,000